triamcinolone acetonide has been researched along with Diabetes Mellitus, Type 2 in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.33) | 18.2507 |
| 2000's | 24 (55.81) | 29.6817 |
| 2010's | 16 (37.21) | 24.3611 |
| 2020's | 2 (4.65) | 2.80 |
| Authors | Studies |
|---|---|
| Shaddoud, I; Zaher Addeen, S | 1 |
| El Naggar, TEDM; Maaty, AIE; Mohamed, AE | 1 |
| Ganne, P; Krishnappa, NC | 1 |
| Bodick, N; Conaghan, PG; Davis, Y; Habib, G; Johnson, JR; Kelley, S; Kivitz, A; Lufkin, J; Manning, R; Russell, SJ; Sala, R; Vo, Q | 1 |
| Feng, J; Jiang, YR; Qu, JF | 1 |
| Bar, A; Din, NM; Isa, H; Lightman, S; Talat, L; Taylor, SR; Tomkins-Netzer, O | 1 |
| Beredjiklian, PK; Hoffler, CE; Kim, N; Lutsky, KF; Matzon, JL; Schroeder, J | 1 |
| Abdulla, FR; Sheth, PB | 1 |
| Dinç, UA; Görgün, E; Kokame, GT; Lim, JI; Yenerel, NM; Yetik, H | 1 |
| Costa, RA; Maia, OO; Scott, IU; Takahashi, BS; Takahashi, WY | 1 |
| Ghosh, B; Goel, N; Kumar, V; Raina, UK | 1 |
| Fukushima, H; Kato, S; Toda, J | 1 |
| Jonas, J; Rensch, F | 1 |
| Gillies, M | 1 |
| Blanco-Garavito, R; Rodriguez-Valdes, PJ | 1 |
| Karacorlu, M; Karacorlu, SA; Ozdemir, H; Senturk, F; Uysal, O | 1 |
| Kim, SJ | 1 |
| Ghosh, B; Goel, N; Kumar, V | 1 |
| Agarwal, M; Chaudhary, SP; Narula, R; Shroff, C | 1 |
| Alimahmoudi, A; Dianat, S; Faghihi, H; Lashay, A; Mirshahi, A; Shenazandi, H | 1 |
| Freeman, WR; Oster, SF; Shah, AM | 1 |
| Kimura, H; Kuroda, S; Toyokawa, N | 1 |
| Aiello, LP; Beck, RW; Bressler, NM; Bressler, SB; Edwards, AR; Elman, MJ; Ferris, FL; Friedman, SM; Glassman, AR; Miller, KM; Scott, IU; Stockdale, CR; Sun, JK | 1 |
| Ahmadabadi, HF; Beheshtnejad, H; Mirshahi, A; Mohammadi, M | 1 |
| Hayashi, H; Kameda, T; Kita, M; Nishijima, K; Oh, H; Sakamoto, A; Unoki, N; Yoshimura, N | 1 |
| Baltă, F; Davidescu, L; Mocanu, C; Olaru, A; Puşcaşu, CR | 1 |
| Arimura, N; Doi, N; Ishibashi, T; Sakamoto, T; Sonoda, Y; Uchino, E; Yasuda, M; Yonemoto, K | 1 |
| Bhaduri, G; Dutta, J; Ghosh, S; Mukhopadhyay, S | 1 |
| Baek, GH; Gong, HS; Lee, SY; Noh, JH; Oh, JH; Roh, YH; Yi, SR | 1 |
| Benz, MS; Dubovy, SR; Eifrig, CW; Katz, RS; Murray, TG | 1 |
| Al-Haddad, CE; Bashshur, ZF; Jurdi, FA | 1 |
| Lang, GE | 1 |
| Avci, R; Kaderli, B | 1 |
| Bardak, Y; Cekiç, O; Tiğ, SU | 1 |
| Bandello, F; Dimastrogiovanni, A; Monaco, P; Paissios, J; Pognuz, DR; Polito, A | 1 |
| Audren, F; Benosman, R; Bergmann, JF; Erginay, A; Gaudric, A; Haouchine, B; Lecleire-Collet, A; Massin, P | 1 |
| La Cour, M; Larsen, M; Lund-Andersen, H; Sander, B; Vinten, M | 1 |
| Aouizérate, F; Delyfer, MN; Hubschman, JP; Korobelnik, JF; Rougier, MB | 1 |
| Aiello, LP; Antoszyk, A; Beck, R; Bressler, N; Browning, D; Chew, E; Danis, R; Fan, J; Flaxel, C; Friedman, S; Glassman, A; Kollman, C; Lazarus, H; Strauber, S | 1 |
| Iida, T; Nakazawa, T; Nishida, K; Sakamoto, T; Shimura, M; Shiono, T; Yasuda, K | 1 |
| Chibani, A; Feldman-Billard, S; Héron, E | 1 |
| Cordingley, JJ; Knight, JW; Palazzo, MG | 1 |
1 review(s) available for triamcinolone acetonide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Pharmacological treatment of diabetic retinopathy].
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Humans; Injections; Macular Edema; Multicenter Studies as Topic; Octreotide; Prospective Studies; Protein Kinase C; Somatostatin; Triamcinolone Acetonide; Vitreous Body | 2004 |
15 trial(s) available for triamcinolone acetonide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Combined phacoemulsification surgery and intravitreal triamcinolone injection versus stand-alone surgery in patients with type 2 diabetes: a prospective randomized trial.
Topics: Cataract; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2022 |
Effectiveness of radial extracorporeal shock-wave therapy versus ultrasound-guided low-dose intra-articular steroid injection in improving shoulder pain, function, and range of motion in diabetic patients with shoulder adhesive capsulitis.
Topics: Aged; Anti-Inflammatory Agents; Bursitis; Diabetes Mellitus, Type 2; Extracorporeal Shockwave Therapy; Female; Humans; Injections, Intra-Articular; Male; Middle Aged; Pain Measurement; Range of Motion, Articular; Shoulder Joint; Shoulder Pain; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Ultrasonography, Interventional | 2020 |
Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Blood Glucose; Blood Glucose Self-Monitoring; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Treatment Outcome; Triamcinolone Acetonide | 2018 |
Elevated Hemoglobin A1C Levels Correlate with Blood Glucose Elevation in Diabetic Patients following Local Corticosteroid Injection in the Hand: A Prospective Study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Carpal Tunnel Syndrome; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucocorticoids; Glycated Hemoglobin; Hand; Humans; Hyperglycemia; Injections; Male; Middle Aged; Prospective Studies; Tendinopathy; Triamcinolone Acetonide | 2015 |
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Topics: Chemotherapy, Adjuvant; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Topics: Aged; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Ranibizumab; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Intraocular Pressure; Lens Implantation, Intraocular; Macula Lutea; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Glycated Hemoglobin; Humans; Intravitreal Injections; Macular Edema; Male; Prospective Studies; Recurrence; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Young Adult | 2012 |
Intra-articular corticosteroid injection in diabetic patients with adhesive capsulitis: a randomized controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bursitis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Male; Middle Aged; Pain Measurement; Range of Motion, Articular; Recovery of Function; Shoulder Joint; Treatment Outcome; Triamcinolone Acetonide | 2012 |
Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Epiretinal Membrane; Female; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Light Coagulation; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2006 |
Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Topics: Adult; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Male; Middle Aged; Prospective Studies; Retinal Neovascularization; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Middle Aged; Prospective Studies; Recurrence; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2006 |
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Orbit; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
27 other study(ies) available for triamcinolone acetonide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Paraproteinemic Maculopathy in a 63-Year-Old Man.
Topics: Angiogenesis Inhibitors; Bevacizumab; Blood Protein Electrophoresis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Retinal Diseases; Stroke; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity | 2018 |
Resolution of diabetic papillopathy with a single intravitreal injection of bevacizumab combined with triamcinolone acetonide.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Male; Optic Disk; Papilledema; Tomography, Optical Coherence; Triamcinolone Acetonide | 2013 |
The influence of diabetes mellitus on the management and visual outcome of patients with uveitis.
Topics: Anti-Inflammatory Agents; Cataract; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Methylprednisolone; Methylprednisolone Acetate; Prediabetic State; Triamcinolone Acetonide; Uveitis; Vision, Low; Visual Acuity | 2014 |
A case of perforating necrobiosis lipoidica in an African American female.
Topics: Black or African American; Diabetes Mellitus, Type 2; Female; Humans; Injections, Intralesional; Leg Dermatoses; Middle Aged; Necrobiosis Lipoidica; Risk Assessment; Severity of Illness Index; Treatment Outcome; Triamcinolone Acetonide | 2008 |
Diagnostic and therapeutic challenges.
Topics: Acetazolamide; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Carbonic Anhydrase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Recurrence; Retina; Sulfonamides; Thiazines; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2009 |
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients.
Topics: Aged; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fasting; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Insulin; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide | 2009 |
Diabetic macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Diabetic macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
DRCR Study: outcomes in focal vs diffuse edema?
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Vitreous Body | 2010 |
Diabetic macular edema.
Topics: Cataract; Cataract Extraction; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Randomized Controlled Trials as Topic; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Injections; Laser Coagulation; Macular Edema; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Diabetic macular edema.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities.
Topics: Adult; Aged; Causality; Cytomegalovirus Retinitis; Diabetes Mellitus, Type 2; Female; Glucocorticoids; Herpes Zoster Ophthalmicus; HIV Infections; Humans; Incidence; Injections; Macular Edema; Male; Middle Aged; Ovarian Neoplasms; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Cytomegalovirus retinitis after subtenon triamcinolone acetonide and intravitreal injection of anti-vascular endothelial growth factor in an immunocompetent patient with age-related macular degeneration and diabetes mellitus.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Cytomegalovirus Retinitis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fascia; Glucocorticoids; Humans; Immunocompromised Host; Injections; Macular Degeneration; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitrectomy; Vitreous Body | 2010 |
Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Glycated Hemoglobin; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Visual Fields | 2011 |
[Current therapeutic approach to diabetic macular edema refractory to laser coagulation].
Topics: Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Injections, Intraocular; Laser Coagulation; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2010 |
Correlation of macular thickness and posterior hyaloid change following bevacizumab and triamcinolone in diffuse diabetic macular edema in middle-aged patients.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Detachment | 2011 |
Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone.
Topics: Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Bacterial; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Triamcinolone Acetonide; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Papilledema; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Exudates and Transudates; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
Topics: Aged; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fluorophotometry; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2007 |
Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases.
Topics: Aged; Cytomegalovirus Retinitis; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Injections; Male; Pseudophakia; Triamcinolone Acetonide; Virus Activation; Visual Acuity; Vitrectomy; Vitreous Body | 2007 |
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Intravitreal triamcinolone and blood glucose.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Retinal Detachment; Triamcinolone Acetonide; Vitrectomy; Vitreous Body; Vitreous Hemorrhage | 2008 |
Epidural abscess following epidural steroid and local anaesthetic injection.
Topics: Abscess; Anesthesia, Epidural; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Epidural Space; Humans; Injections, Epidural; Male; Middle Aged; Paraplegia; Spinal Diseases; Triamcinolone Acetonide | 1997 |